Literature DB >> 8618960

Degeneration and regeneration of axons in the lesioned spinal cord.

M E Schwab1, D Bartholdi.   

Abstract

For many decades, the inability of lesioned central neurons to regrow was accepted almost as a "law of nature", and on the clinical level, spinal cord and brain lesions were seen as being irreversible. Today we are starting to understand the mechanisms of neuronal regeneration in the central nervous system and its presence in the periphery. There is now a rapid expansion in this field of neuroscience. Developmental neurobiology has produced tools and concepts that start to show their impact on regeneration research. This is particularly true for the availability of antibodies and factors and for the rapidly growing cellular and molecular understanding of crucial aspects of neurite growth, guidance, target finding, and synapse stabilization. New cell biological concepts on the mechanisms of neuron survival and death and on the interaction of inflammatory cells with the central nervous system also find their way into the field of spinal cord and brain lesions and have, indeed, led already to new therapeutic approaches. This review briefly summarizes the current knowledge on the mechanisms involved in degeneration and tissue loss and in axonal regeneration subsequent to spinal cord lesions, particularly in mammals and humans.

Entities:  

Mesh:

Year:  1996        PMID: 8618960     DOI: 10.1152/physrev.1996.76.2.319

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  229 in total

1.  Changes in the distribution of synaptic potentials from bulbospinal neurones following axotomy in cat thoracic spinal cord.

Authors:  T W Ford; C W Vaughan; P A Kirkwood
Journal:  J Physiol       Date:  2000-04-01       Impact factor: 5.182

2.  Roles of the telencephalic cells and their chondroitin sulfate proteoglycans in delimiting an anterior border of the retinal pathway.

Authors:  H Ichijo; I Kawabata
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

3.  Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord.

Authors:  D M McTigue; P Wei; B T Stokes
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

4.  Compensatory sprouting and impulse rerouting after unilateral pyramidal tract lesion in neonatal rats.

Authors:  W J Z'Graggen; K Fouad; O Raineteau; G A Metz; M E Schwab; G L Kartje
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

Review 5.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

6.  Purkinje cell survival and axonal regeneration are age dependent: an in vitro study.

Authors:  I Dusart; M S Airaksinen; C Sotelo
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

7.  The developmental loss of the ability of Purkinje cells to regenerate their axons occurs in the absence of myelin: an in vitro model to prevent myelination.

Authors:  Lamia Bouslama-Oueghlani; Rosine Wehrlé; Constantino Sotelo; Isabelle Dusart
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

8.  Modulating Sema3A signal with a L1 mimetic peptide is not sufficient to promote motor recovery and axon regeneration after spinal cord injury.

Authors:  Erik Mire; Nicole Thomasset; Lyn B Jakeman; Geneviève Rougon
Journal:  Mol Cell Neurosci       Date:  2007-10-03       Impact factor: 4.314

9.  S6 kinase inhibits intrinsic axon regeneration capacity via AMP kinase in Caenorhabditis elegans.

Authors:  Thomas Hubert; Zilu Wu; Andrew D Chisholm; Yishi Jin
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

10.  Functional regeneration of chronically injured sensory afferents into adult spinal cord after neurotrophin gene therapy.

Authors:  M I Romero; N Rangappa; M G Garry; G M Smith
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.